Morgan Stanley lowered the firm’s price target on CME Group (CME) to $319 from $320 and keeps an Overweight rating on the shares after updating estimates to reflect reported December and Q4 volumes and the latest RPC trends.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME:
- CME Group expands crypto derivatives suite with three new futures
- CME Group upgraded to Buy at TD Cowen on tactical tilt toward volatility
- CME Group upgraded to Buy from Hold at TD Cowen
- CME Group to launch 100-Ounce Silver futures to meet record retail demand
- CME Group announces FY25 international average daily volume 8.4M contracts